JohnDouglasHudsonMD

Clinical Trials

• Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve Start of enrollment: 2014 Mar 01

  Terminated

  Phase 2

• The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) Start of enrollment: 2013 Nov 01

  Unknown status

  Not Applicable

• 12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01

  Completed

  Phase 3

• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07

  Completed

  Phase 2

• A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 Start of enrollment: 2015 Sep 01

  Completed

  Phase 2

• A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy Start of enrollment: 2017 Mar 14

  Completed

  Phase 3

• Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain Start of enrollment: 2021 Oct 19

  Active, not recruiting

  Phase 2, Phase 3

• Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy Start of enrollment: 2004 Oct 01

  Completed

  Phase 3

• Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome Start of enrollment: 2004 Oct 01

  Completed

  Phase 3

• A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine Start of enrollment: 2021 Jun 30

  Completed

  Phase 3

• Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens Start of enrollment: 2022 Mar 04

  Active, not recruiting

  Phase 4

  Roles: Contact

• Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH Start of enrollment: 2022 Dec 28

  Active, not recruiting

  Phase 2

  Roles: Contact

• Join now to see all